Responses
Oral Presentations
Plenary session 9: young researcher session
09.01 Armoring anti-HER2 CAR-T cells with C-C-motive receptor 8 (CCR8) and a dominant negative TGF-b receptor (DNR) to enable efficacy in solid tumor models
Compose a Response to This Article
Other responses
No responses have been published for this article.